There are studies that show it is reasonably effective for some intractable forms of epilepsy
https://www.nejm.org/doi/full/10.1056/NEJMoa1611618
Indeed there is an official licensed medicinal version called Epidolex and the FDA recently approved it https://www.fda.gov/newsevents/newsroom/pressannouncements/u...
(however this often gets overblown somewhat by the pot lobby, so I share your concerns about snake oil in general)
The paper you cited used “cannabidiol oral solution at a dose of 20 mg per kilogram of body weight”
So for a young adult of 50kg this is 1000mg/day.
Amazon’s maximum dose I could find is 1000mg for $50 [0]. So to get these kinds of benefits someone would need $1500/month.
I would like to see more studies at the kind of doses these retail doses marketed to grandmas (mine in particular).
[0] https://www.amazon.com/Natural-Hemp-Drops-Relief-Essenzia/dp...
>Placebo is a hell of a drug. There is no credible, replicable, evidence that CBD does anything for anyone, and it's done nothing for many people duped into buying it, it's likely acting as a placebo.
To "it works, but it's too expensive." Ok.
Now you are backpedaling saying its expensive. Yes, it is expensive. And I promise you it's not hard to see that it absolutely works for some people. If you understood how well cannibinoids fit into our brains, this may not surprise you.
Having looked into pricing and done quite a bit of research, the cheapest I have seen for pills is 50c for 25mg. But this is still $600/month for a 1000mg dose.
I think most people are taking less than this. But still 300-600mg is expensive. But, its not much more expensive that other "mediciine" that needs to be taken every day.
A $600/month otc treatment is not realistic. I’m really familiar with retail cbd use. I don’t think it’s harmful. But these retail offerings are not advertising 1g/day doses and instead include droppers and market small doses.
I haven’t read any studies that show these low doses having the anecdotal impact.
If it absolutely works for some people, then we’ll have RCTs and published results for us both to discuss. That will be great.
There’s lots of expensive medicine. There’s also medicine that’s dirt cheap ($6/month metformin, $3/month ssris, etc).
With research cbd will be very affordable as well. Because now, it’s only available in the doses in the referenced papers to rich people. Which is nice, but if it is as amazing as folks feel it is then prices really need to come down.
However you are wrong that a $600/month otc treatmnet is not realistic. It's certainly not ideal, it's certainly out of the financial range of many people. .
And certainly there are people right now spending $600/month for CBD because it works.
Prices will definitely come down, and I agree they "need" to. I suspect we will have synthesized CBD quite soon). Minus the black market, and then minus the hype, and then plus the increase in production, prices have a long way to go down.
I don’t know of anything that shows a risk or danger.
I haven't tried it, but I have friends with chronic pain that prefer it to both opiates and OTC painkillers and have for years. That certainly could be placebo, but having seen them cycle through a variety of approaches and stop on CBD, I'd be surprised there's absolutely no effect.
Thats not how scientific research into drugs works. The null hypothesis that you hold by default is that the substance being studied has no effect. The purpose of research is to demonstrate that an effect exists and until that has been shown the null hypothesis is held to be true.
What does exist is lots of link-farm SEO ad copy, people claiming on forums that along with their mega-dosing iodine and salt lamps they've seen drastic changes in their cancer/aids/anxiety/pain, and then gobs and gobs of people claiming anyone that says CBD isn't a cure-all 'has an agenda to push' and/or is being paid 'by big pharma'.
Most sellers of CBD oil are outright committing fraud with claims they make, they have paid influencers (that often don't disclose clearly they are doing a paid endorsement), with fake reviews and almost certainly with armies of fake advertorials on forums.
If CBD does have valid medical benefits, it's almost certain that it will not have anywhere near the current alleged number of applications.
That's clearly a strawman: nothing is a panacea. But here are some links from the first page of Google when I searched for "CBD research":
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189631/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604171/
Each have dozens or more citations and are from reputable scientists at large universities. If your agenda is "the scientific method," hopefully that Google search helped.
We should regulate CBD so that salespeople don't make absurd claims about what it can or can't do. But claiming that it's on par with megadosing iodine or salt lamps is pretty uneducated.
> Until data from well-designed clinical trials are available and reliable, and standardized CBD products that are produced using GMP are available, caution must be exercised in any consideration of using CBD for the treatment of epilepsy. In the meantime, based upon promising preliminary data, further clinical research should be wholeheartedly pursued.
Citing a part of the second paper's Conclusion:
> Human experimental findings support preclinical findings, and also suggest a lack of anxiogenic effects, minimal sedative effects, and an excellent safety profile. Current preclinical and human findings mostly involve acute CBD dosing in healthy subjects, so further studies are required to establish whether chronic dosing of CBD has similar effects in relevant clinical populations. Overall, this review emphasizes the potential value and need for further study of CBD in the treatment of anxiety disorders.
So the second one says it seems good for acute dosing. Both say more research has to be done. Let's hope this is being done in the near future.
Things have changed some in recent years, but it’s still very difficult to do accredited scientific research when something is a scheduled narcotic.